機構稱會德豐(00020.HK)有機會以40%溢價私有化九龍倉集團(00004.HK)
據《彭博通訊社》報道,研究機構United First Partners指出,會德豐(00020.HK)有機會提出以40%溢價私有化九龍倉集團(00004.HK),報道指會德豐有機會以每股27.58元的價錢私有化九倉,較其前收市價為19.7元溢價40%。九倉股價去年跑輸會德豐,九倉股價跌22%而會德豐僅跌12%,認為是時候進行私有化。
而會德豐最大股東吳氏家族自分拆九倉置業(01997.HK)以來一直有私有化九倉的動作,公司有機會潛在發行股份,而私有化後估計吳氏家族在合併後的公司中仍能維持過半持股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.